Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Jul 31, 2025 | FY 2024Jul 31, 2024 |
|---|---|---|
| Total Revenue | 0.00 | -- |
| Operating Revenue | 0.00 | -- |
| Selling General And Administration | 2.1M | -- |
| General And Administrative Expense | 2.0M | -- |
| Depreciation And Amortization In Income Statement | 30,428 | -- |
| Operating Expense | 2.1M | -- |
| Operating Income | -2.1M | -- |
| EBIT | -2.1M | -- |
| Interest Expense | 7,070 | -- |
| Interest Expense Non Operating | 7,070 | -- |
| Interest Income | 13,753 | -- |
| Interest Income Non Operating | 13,753 | -- |
| Net Interest Income | 6,683 | -- |
| Other Income Expense | 63,287 | -- |
| Special Income Charges | -29,758 | -- |
| Write Off | 14,758 | -- |
| Gain On Sale Of Security | 93,045 | -- |
| Pretax Income | -2.1M | -- |
| Tax Effect Of Unusual Items | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -2.1M | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.1M | -- |
| Net Income Including Noncontrolling Interests | -2.1M | -- |
| Net Income Common Stockholders | -2.1M | -- |
| Net Income | -2.1M | -- |
| EBITDA | -2.0M | -- |
| Normalized EBITDA | -2.1M | -- |
| Reconciled Depreciation | 30,428 | -- |
| Basic EPS | -0.02 | -- |
| Diluted EPS | -0.02 | -- |
| Basic Average Shares | 103.8M | -- |
| Diluted Average Shares | 103.8M | -- |
| Total Unusual Items | 63,287 | -- |
| Total Unusual Items Excluding Goodwill | 63,287 | -- |
| Tax Rate For Calcs | 0.00 | -- |
| Normalized Income | -2.1M | -- |
| Amortization | 30,428 | -- |
| Amortization Of Intangibles Income Statement | 30,428 | -- |
| Depreciation Amortization Depletion Income Statement | 30,428 | -- |
| Diluted NI Availto Com Stockholders | -2.1M | -- |
| Impairment Of Capital Assets | 15,000 | -- |
| Net Income Continuous Operations | -2.1M | -- |
| Net Non Operating Interest Income Expense | 6,683 | -- |
| Other Gand A | 1.4M | -- |
| Salaries And Wages | 537,340 | -- |
| Selling And Marketing Expense | 115,541 | -- |
| Total Expenses | 2.1M | -- |
| Line Item | FY 2025Jul 31, 2025 | FY 2024Jul 31, 2024 |
|---|---|---|
| Cash And Cash Equivalents | 4.5M | 140,644 |
| Cash Cash Equivalents And Short Term Investments | 4.5M | 140,644 |
| Cash Financial | 4.5M | 140,644 |
| Receivables | 51,213 | 0.00 |
| Prepaid Assets | 86,452 | 12,000 |
| Current Assets | 4.6M | 152,644 |
| Gross PPE | 1.3M | 15,000 |
| Net PPE | 1.3M | 15,000 |
| Total Non Current Assets | 1.3M | 15,000 |
| Total Assets | 5.9M | 167,644 |
| Current Debt And Capital Lease Obligation | 37,907 | -- |
| Payables And Accrued Expenses | 324,092 | 28,549 |
| Other Current Liabilities | 667,082 | -- |
| Current Liabilities | 1.0M | 28,549 |
| Long Term Debt And Capital Lease Obligation | 6,886 | 0.00 |
| Long Term Capital Lease Obligation | 6,886 | 0.00 |
| Total Non Current Liabilities Net Minority Interest | 2.0M | 0.00 |
| Total Liabilities Net Minority Interest | 3.1M | 28,549 |
| Common Stock | 4.6M | 260,200 |
| Capital Stock | 4.6M | 260,200 |
| Retained Earnings | -2.2M | -121,105 |
| Common Stock Equity | 2.9M | 139,095 |
| Stockholders Equity | 2.9M | 139,095 |
| Total Equity Gross Minority Interest | 2.9M | 139,095 |
| Total Capitalization | 2.9M | 139,095 |
| Net Tangible Assets | 2.9M | 139,095 |
| Tangible Book Value | 2.9M | 139,095 |
| Working Capital | 3.6M | 124,095 |
| Invested Capital | 2.9M | 139,095 |
| Total Debt | 44,793 | 0.00 |
| Share Issued | 103.8M | 103.8M |
| Ordinary Shares Number | 103.8M | 103.8M |
| Capital Lease Obligations | 44,793 | 0.00 |
| Current Capital Lease Obligation | 37,907 | 0.00 |
| Derivative Product Liabilities | 1.9M | 0.00 |
| Non Current Deferred Liabilities | 93,750 | 0.00 |
| Other Equity Interest | 411,379 | -- |
| Other Properties | 1.3M | 15,000 |
| Taxes Receivable | 51,213 | 0.00 |
| Line Item | FY 2025Jul 31, 2025 | FY 2024Jul 31, 2024 |
|---|---|---|
| Operating Cash Flow | -1.3M | -- |
| Cash Flow From Continuing Operating Activities | -1.3M | -- |
| Depreciation And Amortization | 30,428 | -- |
| Depreciation Amortization Depletion | 30,428 | -- |
| Stock Based Compensation | 580,489 | -- |
| Change In Working Capital | 218,470 | -- |
| Change In Receivables | -53,971 | -- |
| Change In Payables And Accrued Expense | 265,143 | -- |
| Change In Other Working Capital | 93,750 | -- |
| Other Non Cash Items | 7,070 | -- |
| Capital Expenditure | -1.3M | -- |
| Purchase Of PPE | -1.3M | -- |
| Net PPE Purchase And Sale | -1.3M | -- |
| Investing Cash Flow | -1.3M | -- |
| Cash Flow From Continuing Investing Activities | -1.3M | -- |
| Repayment Of Debt | -35,660 | -- |
| Net Issuance Payments Of Debt | -35,660 | -- |
| Issuance Of Capital Stock | 6.4M | -- |
| Net Common Stock Issuance | 6.4M | -- |
| Financing Cash Flow | 6.9M | -- |
| Cash Flow From Continuing Financing Activities | 6.9M | -- |
| Changes In Cash | 4.3M | -- |
| Beginning Cash Position | 140,644 | -- |
| End Cash Position | 4.5M | -- |
| Free Cash Flow | -2.6M | -- |
| Asset Impairment Charge | 29,758 | -- |
| Change In Prepaid Assets | -86,452 | -- |
| Common Stock Issuance | 6.4M | -- |
| Depreciation | 30,428 | -- |
| Gain Loss On Investment Securities | -96,983 | -- |
| Long Term Debt Payments | -35,660 | -- |
| Net Income From Continuing Operations | -2.1M | -- |
| Net Long Term Debt Issuance | -35,660 | -- |
| Net Other Financing Charges | -205,900 | -- |
| Operating Gains Losses | -96,983 | -- |
| Proceeds From Stock Option Exercised | 732,500 | -- |